Sbi Securities Co., Ltd. Belite Bio, Inc Transaction History
Sbi Securities Co., Ltd.
- $3.48 Trillion
- Q2 2025
A detailed history of Sbi Securities Co., Ltd. transactions in Belite Bio, Inc stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 52 shares of BLTE stock, worth $3,781. This represents 0.0% of its overall portfolio holdings.
Number of Shares
52
Previous 104
50.0%
Holding current value
$3,781
Previous $6.89 Million
56.44%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BLTE
# of Institutions
17Shares Held
148KCall Options Held
0Put Options Held
0-
Alyeska Investment Group, L.P. Chicago, IL83.6KShares$6.08 Million0.02% of portfolio
-
State Street Corp Boston, MA20.1KShares$1.46 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA12.9KShares$935,5980.0% of portfolio
-
Jpmorgan Chase & CO New York, NY8.16KShares$593,6220.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il5.69KShares$413,7600.0% of portfolio
About BELITE BIO, INC
- Ticker BLTE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,867,400
- Market Cap $1.81B
- Description
- Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery o...